Holen Sie sich die Stockscreener-App
3.485
6.14%
0.205
Schlusskurs vom Vortag:
$3.28
Offen:
$3.32
24-Stunden-Volumen:
604.01K
Relative Volume:
0.14
Marktkapitalisierung:
$1.23B
Einnahmen:
$6.31M
Nettoeinkommen (Verlust:
$-246.87M
KGV:
-2.4879
EPS:
-1.4008
Netto-Cashflow:
$-75.62M
1W Leistung:
+4.86%
1M Leistung:
-29.39%
6M Leistung:
-8.15%
1J Leistung:
+100.07%
1-Tages-Spanne:
$3.32
$3.55
1-Wochen-Bereich:
$3.255
$3.59
52-Wochen-Spanne:
$1.11
$5.465
Precigen Inc Stock (PGEN) Company Profile
Firmenname
Precigen Inc
Sektor
Branche
Telefon
301-556-9900
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
3.485 | 1.16B | 6.31M | -246.87M | -75.62M | -1.4008 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.00 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.24 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
701.00 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.99 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.45 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-03-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Eingeleitet | JP Morgan | Neutral |
| 2022-11-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Eingeleitet | Stifel | Buy |
| 2021-02-22 | Eingeleitet | Wells Fargo | Overweight |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-05-08 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback - simplywall.st
Assessing Precigen (PGEN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Estimates - Yahoo Finance
Precigen (NASDAQ:PGEN) Upgraded at Zacks Research - MarketBeat
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 - Finviz
Biotech firm Precigen schedules March 25 call on 2025 results - Stock Titan
Precigen (PGEN) to Release Quarterly Earnings on Wednesday - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Gainers Report: Is Precigen Inc forming a bullish divergence2025 Geopolitical Influence & Weekly Setup with High ROI Potential - baoquankhu1.vn
Precigen earnings in focus as gene therapy revenue ramps up - Investing.com
Why Precigen (PGEN) Is Down 11.5% After Mixed Quarterly Results And What's Next - Sahm
Precigen (PGEN) Surged Following the Early Approval of Papziemos - Insider Monkey
EV Market: Is Precigen Inc stock influenced by commodity prices2025 Investor Takeaways & Technical Pattern Alert System - baoquankhu1.vn
PGEN Stock Price, Quote & Chart | PRECIGEN INC (NASDAQ:PGEN) - ChartMill
Precigen, Inc. (PGEN) Stock Analysis: Unveiling A 123% Upside Potential In Biotech - DirectorsTalk Interviews
Lansing Street Advisors Takes $1.80 Million Position in Precigen, Inc. $PGEN - MarketBeat
Precigen (NASDAQ:PGEN) Share Price Passes Below Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Aug Update: Can Precigen Inc beat the S P 5002025 Winners & Losers & Safe Capital Growth Tips - baoquankhu1.vn
Precigen, Inc. Hits Day Low of $4.04 Amid Price Pressure - Markets Mojo
Precigen, Inc. Experiences Evaluation Revision Amidst Mixed Market Performance Indicators - Markets Mojo
Precigen, Inc. (PGEN): Investor Outlook On A Biotech With 88% Potential Upside - DirectorsTalk Interviews
Why analysts remain bullish on Precigen Inc. stockMarket Growth Report & Advanced Technical Analysis Signals - mfd.ru
Key Takeaways - StocksToTrade
Precigen (NASDAQ:PGEN) Shares Down 6%What's Next? - MarketBeat
Strategic Moves Boost PGEN Momentum Amidst Market Shifts - StocksToTrade
Precigen (NASDAQ:PGEN) Hits New 12-Month HighHere's What Happened - MarketBeat
Can Precigen Translate PAPZIMEOS Momentum Into Revenue Growth And Shareholder Gains? - RTTNews
Precigen (NASDAQ:PGEN) Trading 5.2% HigherStill a Buy? - MarketBeat
Precigen stock hits 52-week high at 5.23 USD - Investing.com
Commit To Buy Precigen At $4, Earn 26.2% Using Options - Nasdaq
Precigen stock hits 52-week high at 5.23 USD By Investing.com - Investing.com UK
3 High Growth Companies With Strong Insider Ownership - simplywall.st
Will Precigen Inc. stock maintain growth story2025 Volatility Report & Daily Stock Trend Reports - mfd.ru
What are Precigen Inc.’s recent SEC filings showingJuly 2025 Update & Reliable Entry Point Trade Alerts - mfd.ru
Macro Review: Is Precigen Inc stock influenced by commodity pricesJuly 2025 Fed Impact & Verified Chart Pattern Signals - baoquankhu1.vn
Why Precigen Inc. stock remains on watchlistsJuly 2025 Analyst Calls & Risk Controlled Swing Alerts - mfd.ru
Precigen, Inc. (PGEN) Builds Commercial Stage With Global Regulatory Support - Finviz
Precigen, Inc. (PGEN) Stock Analysis: Exploring a Promising 79% Upside Potential in Biotechnology - DirectorsTalk Interviews
Goldman Sachs Penny Stocks: Top 12 Stock Picks - Insider Monkey
Gains Recap: Is Planet Labs PBC stock a buy or sell2025 Market Outlook & Daily Growth Stock Tips - baoquankhu1.vn
Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech (NASDAQ:PGEN) - Seeking Alpha
What are Precigen Inc.’s growth levers2025 Bull vs Bear & Expert Curated Trade Setups - mfd.ru
Precigen, Inc. (NASDAQ:PGEN) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Risk Hedge: What is the dividend yield of Precigen IncJuly 2025 Closing Moves & Weekly Top Gainers Trade List - baoquankhu1.vn
Precigen, Inc. (PGEN) Stock Analysis: Unpacking The 100% Upside Potential - DirectorsTalk Interviews
Market Trends: Is Precigen Inc stock risky to hold nowTrade Ideas & Community Shared Stock Ideas - baoquankhu1.vn
Precigen (PGEN) Is Down 5.7% After Consensus Backs PAPZIMEOS As New First-Line RRP Therapy - simplywall.st
AI Stocks: Can Bioceres Crop Solutions Corp outperform under higher oil pricesMarket Trend Summary & Safe Capital Growth Stock Tips - baoquankhu1.vn
Precigen, Inc. (PGEN) Stock Analysis: 87% Upside Potential Ignites Investor Interest - DirectorsTalk Interviews
Institutional Investors May Overlook Precigen, Inc.'s (NASDAQ:PGEN) Recent US$110m Market Cap Drop as Long-term Gains Remain Positive - 富途牛牛
Precigen to Announce Second Quarter and First Half 2022 Financial Results on August 8th - Nasdaq
Zacks Research Downgrades Precigen (NASDAQ:PGEN) to Strong Sell - MarketBeat
Finanzdaten der Precigen Inc-Aktie (PGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):